| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 04/19/2006 | EP1646624A1 Indoles useful in the treatment of inflammation |
| 04/19/2006 | EP1646392A2 7 and 8 membered heterocyclic cyclopentyl benzylamide modulators of chemokine receptor activity |
| 04/19/2006 | EP1646387A1 Use of indazole derivatives for the treatment of neuropathic pain |
| 04/19/2006 | EP1646384A1 Enema preparation |
| 04/19/2006 | EP1646381A2 Combination therapy for treating chronic inflammatory diseases |
| 04/19/2006 | EP1537112B1 Condensed pyridines and pyrimidines with tie2 (tek) activity |
| 04/19/2006 | EP1448564B1 Substituted indolizine-like compounds and methods of use |
| 04/19/2006 | EP1448184B1 Use of propionyl l-carnitine or one of its pharmacologically acceptable salts for the preparation of a medicine for the treatment of la peyronie s disease |
| 04/19/2006 | EP1370559B1 Triazolopyridines as anti-inflammatory agents |
| 04/19/2006 | EP1368016B1 Parenteral dosage forms comprising a suspension of tramadol salt and diclofenac salt |
| 04/19/2006 | EP1365777B1 Compositions comprising proteoglycan and their use for the treatment of inflammatory conditions |
| 04/19/2006 | EP1339706B1 N-type calcium channel antagonists for the treatment of pain |
| 04/19/2006 | EP1296959B1 Methods and compositions utilizing quinazolinones |
| 04/19/2006 | EP1296692B1 Use of a formulation made of or containing at least one dissimilated milk serum |
| 04/19/2006 | EP1294724B1 Pyrrolo¬2,3-d|pyrimidine compounds as immunosuppressive agents |
| 04/19/2006 | EP1294395B1 A COMBINATION PRODUCT COMPRISING MELAGATRAN AND A FACTOR VIIa INHIBITOR |
| 04/19/2006 | EP1276495B1 Use of recombinant pulmonary surfactant for the early treatment of acute pulmonary diseases |
| 04/19/2006 | EP1239857B1 Dual-release compositions of a cyclooxygenase-2- inhibitor |
| 04/19/2006 | EP1227820B1 Oligosaccharide aldonic acids and their topical use |
| 04/19/2006 | EP1143806B1 Method for increasing pet activity |
| 04/19/2006 | EP1003479B1 Method and compositions for treating late phase allergic reactions and inflammatory diseases |
| 04/19/2006 | CN1761686A Proteoglycan isolated from cartilaginous fish and process for producing the same |
| 04/19/2006 | CN1761649A Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase A2 |
| 04/19/2006 | CN1761645A Sulfonic acids, their derivatives and pharmaceutical compositions containing them |
| 04/19/2006 | CN1761462A Patch containing nonsteroidal antiinflammatory and analgesic agent |
| 04/19/2006 | CN1759864A Medicine wine for activating the channels |
| 04/19/2006 | CN1759863A Recipe of drop pills of corydalis and its preparation method |
| 04/19/2006 | CN1759860A Compound unique oil drop pills and preparation method |
| 04/19/2006 | CN1759858A Prescription of compound unique oil drop pills and preparation method |
| 04/19/2006 | CN1759850A PRescription of safflower drop pills, and preparation method |
| 04/19/2006 | CN1759848A Prescription of storax oil drop pills, and preparation method |
| 04/19/2006 | CN1759845A Series of recipe of alive liver cell element, and application |
| 04/19/2006 | CN1252075C Complex ML(DCA) of copper(óÄ), gallium(ó¾) and rare earth ion(Ln**) containing non-methyl canthridic acid radical |
| 04/19/2006 | CN1252070C Urea substituted imidazoquinolines |
| 04/19/2006 | CN1252068C Heteroaryl derivatives as superior ligands for nociceptin receptor ORL-1 |
| 04/19/2006 | CN1252067C Benzazole derivatives and their use as JNK modulators |
| 04/19/2006 | CN1252065C Cinnoline compounds |
| 04/19/2006 | CN1252040C Novel aryl, alkenyl and alkynl 4-dedimethylamino tetracycline derivatives |
| 04/19/2006 | CN1251736C Chinese medicinal infusion for treating shingles, parotitis acute mamitis and its manufacturing method |
| 04/19/2006 | CN1251718C Chinese medicine formula for preventing and treating pyemia and preparing method thereof |
| 04/19/2006 | CN1251676C Phenyl xanthine derivative |
| 04/18/2006 | US7030242 Selective inhibition of aggrecanase in osteoarthritis treatment |
| 04/18/2006 | US7030238 C-nitroso compounds and use thereof |
| 04/18/2006 | US7030225 Antibodies to JTT-1 protein, cells secreting such antibodies, and methods of making such antibodies |
| 04/18/2006 | US7030218 Extending ligation technique to peptides, polypeptides, other polymers and other molecules via an amide bond; used in the synthesis of optionally polymer-modified, synthetic bioactive proteins, and of pharmaceutical compositions |
| 04/18/2006 | US7030135 A sulfonylamino-tetrahydro(1,3)thiazolo(5,4-c)pyridinyl or benzothiazole derivatives, for treating diabetes, syndrome X, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, osteoporosis, tuberculosis, dementia |
| 04/18/2006 | US7030123 Indole derivatives with vascular damaging activity |
| 04/18/2006 | US7030107 nitrogen compounds such as 5-[3,5-bis(trifluoromethyl)benzyl]-6-oxo-7-phenyl-9-[4-(pyrrolidine-1-yl)piperidine-1-yl]-2,3,4,5-tetrahydro-6H-pyrido[2,3-b][1,5]oxazocine, used as neurokinin inhibitors for prophylaxis of urogenital disorders; side effect reduction |
| 04/18/2006 | US7030090 Immune-modulating peptide |
| 04/18/2006 | US7030086 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 04/18/2006 | US7029914 DNA encoding SNORF36 receptors |
| 04/18/2006 | US7029894 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 04/18/2006 | US7029877 binding protease thrombin to phosphoethanolamine binding protein |
| 04/18/2006 | US7029872 Methods for producing modified glycoproteins |
| 04/18/2006 | US7029713 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising the same |
| 04/18/2006 | US7029688 Methods and compositions to prevent formation of adhesions in biological tissues |
| 04/18/2006 | US7029663 substantially anhydrous, using hydrocarbon gel and/or petrolatum as a base; increased storage stability |
| 04/18/2006 | US7029658 Delivery of antidepressants through an inhalation route |
| 04/13/2006 | WO2006039639A1 Crystalline forms and process for preparing spiro-hydantoin compounds |
| 04/13/2006 | WO2006038871A1 New hydroxymethylbenzothiazoles amides |
| 04/13/2006 | WO2006038738A1 Receptor function regulating agent |
| 04/13/2006 | WO2006038734A1 Pyridazinone derivatives cytokines inhibitors |
| 04/13/2006 | WO2006012373A3 Combination therapies of hmgb and complement inhibitors against inflammation |
| 04/13/2006 | US20060079713 Novel salt forms of poorly soluble probucol esters and ethers |
| 04/13/2006 | US20060079670 98 human secreted proteins |
| 04/13/2006 | US20060079577 Lipoxins and aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases |
| 04/13/2006 | US20060079572 Novel bioactive substance |
| 04/13/2006 | US20060079563 Cyclic protein tyrosine kinase inhibitors |
| 04/13/2006 | US20060079548 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 04/13/2006 | US20060079525 antiinflammatory agent N-{[(2S)-4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}cyclopropane carboxamide; bronchitis, asthma, chronic obstructive pulmonary disease and rhinitis |
| 04/13/2006 | US20060079489 Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine |
| 04/13/2006 | US20060078963 Methods for producing modified glycoproteins |
| 04/13/2006 | US20060078956 Methods to identify compounds that modulate rage |
| 04/13/2006 | US20060078940 21132, a human G-protein coupled receptor family member and uses therefor |
| 04/13/2006 | US20060078918 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator |
| 04/13/2006 | US20060078878 Cell containing nucleic acid molecule comprising polynucleotide sequence encoding engineered zinc finger protein operably linked to promoter, contacting target site in endogenous cellular gene with protein to inhibit transcription |
| 04/13/2006 | US20060078582 Use of compositions for treating rosacea |
| 04/13/2006 | US20060078568 Use of the residues from wine production |
| 04/13/2006 | US20060078551 Polynucleotide that encodes a polypeptide having activity as a phospholipase A2 inhibitor; especially obtained from the liver of a species of Python |
| 04/13/2006 | US20060078547 Lactobacillus salivarius strain, AH102, AH103, AH105, AH109 or AH110 or mutants or variants are useful in the prophylaxis and/or treatment undesirable gastrointestinal inflammatory activity, such as inflammatory bowel disease or irritable bowel syndrome |
| 04/13/2006 | US20060078537 Mono-and dual chemokine/cytokine constructs |
| 04/13/2006 | DE10320633B4 Verfahren zur Identifizierung einer möglichen Modifikation von mindestens einem biologischen Parameter unter Verwendung von lebenden Zellen, die einem Reiz ausgesetzt wurden, und lebenden Zellen, die nicht diesem Reiz ausgesetzt wurden A method of identifying a possible modification of at least one biological parameter using living cells that were exposed to a stimulus, and living cells that were not exposed to this stimulus |
| 04/13/2006 | DE102004023635A1 Heteroarylsubstituierte Cyclohexyl-1,4-diamin-Derivate Heteroaryl-cyclohexyl-1,4-diamine derivatives |
| 04/13/2006 | CA2583326A1 Receptor function regulating agent |
| 04/13/2006 | CA2562151A1 Oligonucleotides comprising a c5-modified pyrimidine |
| 04/13/2006 | CA2561993A1 Compositions and methods for modulating gated ion channels |
| 04/12/2006 | EP1645624A1 Nerve cells obtained by electrical pulse treatment es cell |
| 04/12/2006 | EP1645270A2 Control of pain with endogenous cannabinoids |
| 04/12/2006 | EP1644742A2 Diagnostics and therapeutics for diseases associated with dopamine receptor d1a (drd1) |
| 04/12/2006 | EP1644360A1 3-substituted indoles and derivatives thereof as therapeutic agents |
| 04/12/2006 | EP1644353A1 Amide-substituted 1,2,4-triazin-5(2h)-ones for the treatment of chronically inflammatory diseases |
| 04/12/2006 | EP1644042A1 A pharmaceutical composition containing a p2x7 receptor antagonist and methotrexate |
| 04/12/2006 | EP1644041A1 A pharmaceutical composition comprising a p2x7 antagonist and sulfasalazine |
| 04/12/2006 | EP1644032A1 Inhibitors of cell migration |
| 04/12/2006 | EP1644031A1 Inhibitors of the leukocyte prommp-9/beta(2) integrin complex |
| 04/12/2006 | EP1644002A1 Multiparticulates |
| 04/12/2006 | EP1643961A2 Cox-2 and faah inhibitors |
| 04/12/2006 | EP1423436B1 Use of heparinoid derivatives for treating and diagnosing diseases that can be treated by heparinoids |
| 04/12/2006 | EP1404174A4 Anti-infective compositions for treating disordered tissue such as cold sores |
| 04/12/2006 | EP1358183B1 Cysteine protease inhibitors |